{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05688735",
            "orgStudyIdInfo": {
                "id": "IDEAS_PEDS_AD"
            },
            "organization": {
                "fullName": "Integrative Skin Science and Research",
                "class": "INDUSTRY"
            },
            "briefTitle": "Assessment of the Effect of Coconut and Sunflower Seed Oil Derived Isosorbide Diseters and Colloidial Oatmeal",
            "officialTitle": "Prospective Randomized Vehicle-Controlled, Double-Blind Assessment of the Effect of Coconut and Sunflower Seed Oil Derived Isosorbide Diseters and Colloidial Oatmeal",
            "therapeuticArea": [
                "Dermatology"
            ],
            "study": "assessment-of-the-effect-of-coconut-and-sunflower-seed-oil-derived-isosorbide-diseters-and-colloidial-oatmeal"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-04-20",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-09",
            "studyFirstSubmitQcDate": "2023-01-09",
            "studyFirstPostDateStruct": {
                "date": "2023-01-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-04-12",
            "lastUpdatePostDateStruct": {
                "date": "2023-04-14",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Integrative Skin Science and Research",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Sytheon Ltd.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to compare coconut oil and sunflower seed oil derived isosorbide disesters and colloidal oatmeal, and observe their effect on pediatric atopic dermatitis among males and females aged 2-17."
        },
        "conditionsModule": {
            "conditions": [
                "Atopic Dermatitis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "maskingDescription": "Double-blind, randomized",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Experimental Topical Product",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Topical moisturizer With Colloidal Oatmeal and Isosorbide Diesters + Topical Steroids",
                    "interventionNames": [
                        "Other: Isosorbide Diester Moisturizer"
                    ]
                },
                {
                    "label": "Control Topical Product",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Topical moisturizer With Colloidal Oatmeal WITHOUT Isosorbide Diesters + Topical Steroids",
                    "interventionNames": [
                        "Other: Control Moisturizer"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Isosorbide Diester Moisturizer",
                    "description": "Isosorbide Diesters (with 0.1% colloidal oatmeal) + Topical Hydrocortisone 2.5% ointment",
                    "armGroupLabels": [
                        "Experimental Topical Product"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Control Moisturizer",
                    "description": "Topical vehicle (with 0.1% colloidal oatmeal) + Topical Hydrocortisone 2.5 % ointment",
                    "armGroupLabels": [
                        "Control Topical Product"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Eczema Area and Severity Index (EASI)",
                    "description": "Percent Achieving EASI 75",
                    "timeFrame": "8 Weeks"
                },
                {
                    "measure": "Itch",
                    "description": "Change in the Itch Visual Analog Scale from Baseline",
                    "timeFrame": "8 Weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Eczema Area and Severity Index (EASI)",
                    "description": "Change in the EASI score",
                    "timeFrame": "1 Week"
                },
                {
                    "measure": "Eczema Area and Severity Index (EASI)",
                    "description": "Change in the EASI score",
                    "timeFrame": "4 Weeks"
                },
                {
                    "measure": "Eczema Area and Severity Index (EASI)",
                    "description": "Change in the EASI score",
                    "timeFrame": "8 Weeks"
                },
                {
                    "measure": "Itch",
                    "description": "Change in the Itch Visual Analog Scale",
                    "timeFrame": "1 Week"
                },
                {
                    "measure": "Itch",
                    "description": "Change in the Itch Visual Analog Scale",
                    "timeFrame": "4 Weeks"
                },
                {
                    "measure": "Topical steroid use",
                    "description": "Cumulative use of topical steroid use",
                    "timeFrame": "1 Week"
                },
                {
                    "measure": "Topical steroid use",
                    "description": "Cumulative use of topical steroid use",
                    "timeFrame": "4 Weeks"
                },
                {
                    "measure": "Topical steroid use",
                    "description": "Cumulative use of topical steroid use",
                    "timeFrame": "8 Weeks"
                },
                {
                    "measure": "Skin Transepidermal Water Loss (TEWL)",
                    "description": "TEWL measured with a Vapometer",
                    "timeFrame": "1 Week"
                },
                {
                    "measure": "Skin Transepidermal Water Loss (TEWL)",
                    "description": "TEWL measured with a Vapometer",
                    "timeFrame": "4 Weeks"
                },
                {
                    "measure": "Skin Transepidermal Water Loss (TEWL)",
                    "description": "TEWL measured with a Vapometer",
                    "timeFrame": "8 Weeks"
                },
                {
                    "measure": "Skin Hydration",
                    "description": "Level of skin hydration measured SkinMoistureMeterSC",
                    "timeFrame": "1 week"
                },
                {
                    "measure": "Skin Hydration",
                    "description": "Level of skin hydration measured SkinMoistureMeterSC",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Skin Hydration",
                    "description": "Level of skin hydration measured SkinMoistureMeterSC",
                    "timeFrame": "8 weeks"
                },
                {
                    "measure": "Shift in the Skin Microbiome",
                    "description": "Change in the relative abundance of Staphylococcus aureus on the skin",
                    "timeFrame": "8 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Males and females ages 2-17 years old at the time of consent.\n* Clinical diagnosis of active atopic dermatitis\n* vIGA-AD (validated Investigator Global Assessment-Atopic Dermatitis) score of \"mild\" (2) or \"moderate\" (3) at Baseline\n* EASI (Eczema Area and Severity Index) score of \\>/= 5 at Baseline\n\nExclusion Criteria:\n\n* Individuals who have a known allergy to isosorbide diesters, coconut oil, or sunflower seed oil\n* Individuals who have solely hand and/or foot eczema without evidence of eczema anywhere else on their body.\n* Individuals who have been on topical calcineurin inhibitors or crisaborole to the predetermined areas within two weeks of initiation of participation or unwilling to undergo a washout period.\n* Subjects with an ongoing secondary infection of the skin.\n* Subjects who are on systemic therapy or who need systemic therapy at the discretion of the investigator. Systemic therapies include cyclosporine, systemic steroids, methotrexate, and dupilumab. Subjects who have been on cyclosporine, systemic steroids, or methotrexate in the month prior to initiation of study intervention or are unwilling to undergo a washout period. Subjects who have been on dupilumab in two months prior to initiation of study intervention or are unwilling to undergo a washout period.\n* Subjects with a diagnosis of Scabies.\n* Pregnant women\n* Prisoners",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "2 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Raja Sivamani, MD",
                    "role": "CONTACT",
                    "phone": "(916) 750-2463",
                    "email": "raja.sivamani@integrativeskinresearch.com"
                }
            ],
            "locations": [
                {
                    "facility": "Integrative Skin Science and Research",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95815",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Caitlin Dion",
                            "role": "CONTACT",
                            "phone": "916-750-2463",
                            "email": "caitlin@integrativeskinresearch.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003872",
                    "term": "Dermatitis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7071",
                    "name": "Dermatitis, Atopic",
                    "relevance": "LOW"
                },
                {
                    "id": "M7067",
                    "name": "Dermatitis",
                    "asFound": "Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7655",
                    "name": "Eczema",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007547",
                    "term": "Isosorbide"
                },
                {
                    "id": "D000007548",
                    "term": "Isosorbide Dinitrate"
                },
                {
                    "id": "C000030397",
                    "term": "Isosorbide-5-mononitrate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004234",
                    "term": "Diuretics, Osmotic"
                },
                {
                    "id": "D000004232",
                    "term": "Diuretics"
                },
                {
                    "id": "D000045283",
                    "term": "Natriuretic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000014665",
                    "term": "Vasodilator Agents"
                },
                {
                    "id": "D000020030",
                    "term": "Nitric Oxide Donors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9912",
                    "name": "Hydrocortisone",
                    "relevance": "LOW"
                },
                {
                    "id": "M155245",
                    "name": "Hydrocortisone 17-butyrate 21-propionate",
                    "relevance": "LOW"
                },
                {
                    "id": "M228609",
                    "name": "Hydrocortisone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M263259",
                    "name": "Hydrocortisone hemisuccinate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10578",
                    "name": "Isosorbide",
                    "asFound": "Acalabrutinib",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10579",
                    "name": "Isosorbide Dinitrate",
                    "asFound": "Acalabrutinib",
                    "relevance": "HIGH"
                },
                {
                    "id": "M244430",
                    "name": "Isosorbide-5-mononitrate",
                    "asFound": "Acalabrutinib",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7411",
                    "name": "Diuretics",
                    "relevance": "LOW"
                },
                {
                    "id": "M17412",
                    "name": "Vasodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M12507",
                    "name": "Nitric Oxide",
                    "relevance": "LOW"
                },
                {
                    "id": "T119",
                    "name": "Coconut",
                    "relevance": "LOW"
                },
                {
                    "id": "T305",
                    "name": "Sunflower",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                },
                {
                    "abbrev": "NiOxD",
                    "name": "Nitric Oxide Donors"
                },
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "HB",
                    "name": "Herbal and Botanical"
                }
            ]
        }
    },
    "hasResults": false
}